AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7882730 — intervention group
Group type: EXPERIMENTAL
Intervention: RYHB vaccine (20 micrograms per dose)
Number of subjects: 106
Study 7882730 — intervention group
Group type: COMPARATOR
Intervention: PHB vaccine (20 micrograms per dose)
Number of subjects: 106
Study 2908752 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 100
Study 2908752 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 100
Study 30219195 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural block (GI)
Number of subjects: 80
Study 30219195 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural block (GII)
Number of subjects: 80
Study 30219195 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural block (GI) and Continuous epidural block (GII)
Number of subjects: 80
Study 30025713 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity extracorporeal shockwave therapy given over 2 weeks
Number of subjects: 0
Study 26947417 — intervention group
Group type: EXPERIMENTAL
Intervention: Pisces group (born under the sign of Pisces)
Number of subjects: 798
Study 26947417 — intervention group
Group type: COMPARATOR
Intervention: Non-Pisces group (not born under the sign of Pisces)
Number of subjects: 798
Study 24806159 — intervention group
Group type: EXPERIMENTAL
Intervention: Letermovir 60 mg per day
Number of subjects: 131
Study 24806159 — intervention group
Group type: EXPERIMENTAL
Intervention: Letermovir 120 mg per day
Number of subjects: 131
Study 24806159 — intervention group
Group type: EXPERIMENTAL
Intervention: Letermovir 240 mg per day
Number of subjects: 131
Study 24806159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 22089962 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation combined with passive locomotion-like movement
Number of subjects: 27
Study 22089962 — intervention group
Group type: COMPARATOR
Intervention: Electrical stimulation
Number of subjects: 27
Study 22089962 — intervention group
Group type: COMPARATOR
Intervention: Passive locomotion-like movement
Number of subjects: 27
Study 19806284 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip protectors that have undergone adequate biomechanical testing
Number of subjects: 0
Study 19806284 — intervention group
Group type: COMPARATOR
Intervention: Sham hip protectors
Number of subjects: 0
Study 17050656 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 22
Study 17050656 — intervention group
Group type: COMPARATOR
Intervention: Amisulpride
Number of subjects: 22
Study 16187862 — intervention group
Group type: EXPERIMENTAL
Intervention: Social condition (participants expected to meet the person who induced anger)
Number of subjects: 0
Study 16187862 — intervention group
Group type: COMPARATOR
Intervention: Nonsocial condition (participants had no expectation to meet the person who induced anger)
Number of subjects: 0
Study 16187862 — intervention group
Group type: EXPERIMENTAL
Intervention: Social appraisal
Number of subjects: 0
Study 12231566 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE+MP or MPA
Number of subjects: 35
Study 10604643 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosfomycin treatment within the first two days of illness
Number of subjects: 292
Study 10604643 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosfomycin treatment on the second day of illness
Number of subjects: 292
Study 10604643 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosfomycin treatment on and after the third day of illness
Number of subjects: 292
Study 10604643 — intervention group
Group type: COMPARATOR
Intervention: No antimicrobial agents
Number of subjects: 292
Study 7499739 — intervention group
Group type: EXPERIMENTAL
Intervention: Cordocentesis
Number of subjects: 21
Study 7499739 — intervention group
Group type: COMPARATOR
Intervention: Amniocentesis
Number of subjects: 21
Study 1743247 — intervention group
Group type: EXPERIMENTAL
Intervention: propoxyphene + ethanol
Number of subjects: 12
Study 1743247 — intervention group
Group type: COMPARATOR
Intervention: placebo + ethanol
Number of subjects: 12
Study 1743247 — intervention group
Group type: COMPARATOR
Intervention: propoxyphene alone
Number of subjects: 12
Study 6764935 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan (3 grams daily)
Number of subjects: 30
Study 6764935 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 6764935 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Tryptophan and Placebo)
Number of subjects: 30
Study 31142533 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% olanexidine
Number of subjects: 0
Study 31142533 — intervention group
Group type: COMPARATOR
Intervention: 10% povidone-iodine
Number of subjects: 0
Study 28660649 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 4262
Study 28660649 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 4262
Study 26076313 — intervention group
Group type: EXPERIMENTAL
Intervention: Assist (talk about quitting or recommend stop‐smoking medications or recommend counseling)
Number of subjects: 3336
Study 26076313 — intervention group
Group type: EXPERIMENTAL
Intervention: Arrange follow‐up
Number of subjects: 3336
Study 26076313 — intervention group
Group type: COMPARATOR
Intervention: Ask
Number of subjects: 3336
Study 26076313 — intervention group
Group type: COMPARATOR
Intervention: Advise
Number of subjects: 3336
Study 26076313 — intervention group
Group type: COMPARATOR
Intervention: Assess
Number of subjects: 3336
Study 26076313 — intervention group
Group type: EXPERIMENTAL
Intervention: Assist
Number of subjects: 3336
Study 23498969 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Lifestyle Group (ILG)
Number of subjects: 27
Study 23498969 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner Lifestyle Group (PLG)
Number of subjects: 27
Study 21454746 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin surface cooling (∼12-15°C)
Number of subjects: 8
Study 21454746 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (∼34°C)
Number of subjects: 8
Study 19584748 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory repetitive transcranial magnetic stimulation applied to the contralesional motor system
Number of subjects: 9
Study 19584748 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory paired associative stimulation applied to the contralesional motor system
Number of subjects: 9
Study 19584748 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitatory anodal transcranial direct current stimulation applied to the ipsilesional motor system
Number of subjects: 9
Study 17295725 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.7 g/kg males; 0.63 g/kg females)
Number of subjects: 180
Study 17295725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 17295725 — intervention group
Group type: EXPERIMENTAL
Intervention: Drink after stress (DAS)
Number of subjects: 180
Study 17295725 — intervention group
Group type: COMPARATOR
Intervention: No stress control (NSC)
Number of subjects: 180
Study 17295725 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective desire for alcohol under alcohol condition
Number of subjects: 180
Study 15214221 — intervention group
Group type: EXPERIMENTAL
Intervention: Early loading of implants with full-arch prostheses after 9 to 18 days
Number of subjects: 24
Study 15214221 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading of implants with full-arch prostheses after 2.5 to 5.1 months
Number of subjects: 24
Study 11822766 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vinorelbine at a dose of 80 mg/m2
Number of subjects: 32
Study 11822766 — intervention group
Group type: COMPARATOR
Intervention: Intravenous vinorelbine at a dose of 25 mg/m2
Number of subjects: 32
Study 9805321 — intervention group
Group type: EXPERIMENTAL
Intervention: Forebrain commissurotomy (L.B.)
Number of subjects: 2
Study 9805321 — intervention group
Group type: EXPERIMENTAL
Intervention: Agenesis of the corpus callosum (R.B.)
Number of subjects: 2
Study 9805321 — intervention group
Group type: COMPARATOR
Intervention: Normal participants
Number of subjects: 2
Study 7702447 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Number of subjects: 99
Study 7702447 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal interpersonal therapy
Number of subjects: 99
Study 7702447 — intervention group
Group type: COMPARATOR
Intervention: Behavior therapy
Number of subjects: 99
Study 2084236 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) therapy
Number of subjects: 45
Study 32776 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (3.2 mg twice daily)
Number of subjects: 95
Study 32776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 31925984 — intervention group
Group type: EXPERIMENTAL
Intervention: Definitive abutment group (DEF)
Number of subjects: 24
Study 31925984 — intervention group
Group type: COMPARATOR
Intervention: Healing abutment group (HEA)
Number of subjects: 24
Study 31925984 — intervention group
Group type: EXPERIMENTAL
Intervention: DEF
Number of subjects: 24
Study 31925984 — intervention group
Group type: COMPARATOR
Intervention: HEA
Number of subjects: 24
Study 31925984 — intervention group
Group type: EXPERIMENTAL
Intervention: DEF and HEA
Number of subjects: 24
Study 31734672 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin plus levocetirizine
Number of subjects: 100
Study 31734672 — intervention group
Group type: COMPARATOR
Intervention: Isotretinoin alone
Number of subjects: 100
Study 28396102 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg
Number of subjects: 1196
Study 28396102 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg
Number of subjects: 1196
Study 28396102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1196
Study 25873189 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (CR)
Number of subjects: 84
Study 25873189 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 84
Study 23525572 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback about joint position (pF-group)
Number of subjects: 0
Study 23525572 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback about force (fF-group)
Number of subjects: 0
Study 23525572 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthreshold transcranial magnetic stimulation over the right motor cortex
Number of subjects: 0
Study 20143449 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 259
Study 20143449 — intervention group
Group type: COMPARATOR
Intervention: Control (no GM-CSF)
Number of subjects: 259
Study 18478206 — intervention group
Group type: EXPERIMENTAL
Intervention: Metyrapone, 1500 mg
Number of subjects: 82
Study 18478206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 16098636 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414 vaccine (104.7, 105.2 or 105.8 ffu)
Number of subjects: 2155
Study 12932243 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% pyrithione zinc shampoo
Number of subjects: 200
Study 12932243 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% minoxidil topical solution
Number of subjects: 200
Study 12932243 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 1% pyrithione zinc shampoo and 5% minoxidil topical solution
Number of subjects: 200
Study 12932243 — intervention group
Group type: COMPARATOR
Intervention: Placebo shampoo
Number of subjects: 200
Study 10785587 — intervention group
Group type: EXPERIMENTAL
Intervention: Various statistical techniques for analyzing Quality of Life (QL) data
Number of subjects: 0
Study 10785587 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary statistical methods for QL analysis
Number of subjects: 0
Study 10785587 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity or supportive analysis
Number of subjects: 0
Study 8865946 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime 1.5 g as single shot prophylaxis before hemodilution (group A)
Number of subjects: 20
Study 8865946 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime 1.5 g as single shot prophylaxis after hemodilution (group B)
Number of subjects: 20
Study 1909700 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesna (20% of ifosfamide dose, intravenously, three times daily for 5 days)
Number of subjects: 91
Study 1909700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 1909700 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesna
Number of subjects: 91
Study 6090258 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (opioid blocker)
Number of subjects: 0
Study 6090258 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenergic blockers (phentolamine and propranolol)
Number of subjects: 0
Study 6090258 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of opioid and adrenergic blockers
Number of subjects: 0
Study 6090258 — intervention group
Group type: COMPARATOR
Intervention: Labyrinthine stimulation (active stressful stimulus)
Number of subjects: 0
Study 6090258 — intervention group
Group type: COMPARATOR
Intervention: Cold pain (active stressful stimulus)
Number of subjects: 0
Study 6090258 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenergic blockade during labyrinthine stimulation
Number of subjects: 0
Study 6090258 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 0
Study 6090258 — intervention group
Group type: COMPARATOR
Intervention: Active stressful stimuli (labyrinthine stimulation, cold pain, or both)
Number of subjects: 0
Study 30878146 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group (clinical trial participants)
Number of subjects: 79
Study 30577809 — intervention group
Group type: EXPERIMENTAL
Intervention: Slide-show message
Number of subjects: 30
Study 30577809 — intervention group
Group type: EXPERIMENTAL
Intervention: Video message
Number of subjects: 30
Study 30577809 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard method
Number of subjects: 30
Study 30577809 — intervention group
Group type: EXPERIMENTAL
Intervention: All methods combined
Number of subjects: 30
Study 26341915 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-n-butylresorcinol DMN patch
Number of subjects: 45
Study 26341915 — intervention group
Group type: COMPARATOR
Intervention: Control (DMN without 4-n-butylresorcinol)
Number of subjects: 45
Study 24513622 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxic training (IHT)
Number of subjects: 12
Study 24513622 — intervention group
Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 12
Study 23061875 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking and Behavioural intervention (WB)
Number of subjects: 222
Study 23061875 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking intervention (W)
Number of subjects: 222
Study 23061875 — intervention group
Group type: COMPARATOR
Intervention: Self-directed control (C)
Number of subjects: 222
Study 23061875 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (WB, W, C)
Number of subjects: 222
Study 21252605 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapulothoracic exercises in addition to glenohumeral ROM exercises
Number of subjects: 29
Study 21252605 — intervention group
Group type: COMPARATOR
Intervention: Glenohumeral ROM exercises only
Number of subjects: 29
Study 17624475 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Dose Computed Tomography (LDCT)
Number of subjects: 765
Study 17624475 — intervention group
Group type: COMPARATOR
Intervention: Chest X-ray (CXR)
Number of subjects: 765
Study 17346594 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridated elastomerics
Number of subjects: 12
Study 17346594 — intervention group
Group type: COMPARATOR
Intervention: Nonfluoridated elastomerics
Number of subjects: 12
Study 15685819 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus paclitaxel
Number of subjects: 221
Study 15685819 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel alone
Number of subjects: 221
Study 10865313 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 CGE
Number of subjects: 188
Study 10865313 — intervention group
Group type: COMPARATOR
Intervention: 70 CGE
Number of subjects: 188
Study 9250827 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐6 administered at 1 micro/kg/day for 3 patients
Number of subjects: 6
Study 9250827 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐6 administered at 2.5 microg/kg/day for 3 patients
Number of subjects: 6
Study 9250827 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐6
Number of subjects: 6
Study 9250827 — intervention group
Group type: COMPARATOR
Intervention: GM‐CSF (historical control)
Number of subjects: 6
Study 8472520 — intervention group
Group type: EXPERIMENTAL
Intervention: ST‐679 (1200 mg, single oral dose)
Number of subjects: 40
Study 8472520 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (1000 mg, single oral dose)
Number of subjects: 40
Study 2951799 — intervention group
Group type: EXPERIMENTAL
Intervention: Duovent (fenoterol-ipratropium bromide)
Number of subjects: 16
Study 2951799 — intervention group
Group type: COMPARATOR
Intervention: Terbutaline
Number of subjects: 16
Study 2951799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30421268 — intervention group
Group type: EXPERIMENTAL
Intervention: Religion-spiritual program (6 sessions, 30-45 min each)
Number of subjects: 93
Study 30421268 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 93
Study 27746239 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation during pregnancy
Number of subjects: 333
Study 27746239 — intervention group
Group type: EXPERIMENTAL
Intervention: C-section birth
Number of subjects: 333
Study 27746239 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-feeding
Number of subjects: 333
Study 27746239 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord blood vitamin D levels
Number of subjects: 333
Study 25650964 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic gastric bypass
Number of subjects: 60
Study 25650964 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic duodenal switch
Number of subjects: 60
Study 25650964 — intervention group
Group type: COMPARATOR
Intervention: Comparison between gastric bypass and duodenal switch
Number of subjects: 60
Study 24338119 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 49
Study 24338119 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 49
Study 20817859 — intervention group
Group type: EXPERIMENTAL
Intervention: SDAP (10% spray-dried animal plasma)
Number of subjects: 36
Study 20817859 — intervention group
Group type: EXPERIMENTAL
Intervention: auSDAP (10% autoclaved spray-dried animal plasma)
Number of subjects: 36
Study 20817859 — intervention group
Group type: COMPARATOR
Intervention: Control (fish meal basal diet)
Number of subjects: 36
Study 19387397 — intervention group
Group type: EXPERIMENTAL
Intervention: CM (5 g of creatine)
Number of subjects: 58
Study 19387397 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG1.25 (1.25 g of creatine)
Number of subjects: 58
Study 19387397 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG2.50 (2.50 g of creatine)
Number of subjects: 58
Study 19387397 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (CM, PEG1.25, PEG2.50)
Number of subjects: 58
Study 19387397 — intervention group
Group type: COMPARATOR
Intervention: PL (placebo; 3.6 g of microcrystalline cellulose)
Number of subjects: 58
Study 17451421 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg per day
Number of subjects: 39
Study 17451421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 14758131 — intervention group
Group type: EXPERIMENTAL
Intervention: Temozolomide 200 mg/m2 daily for 5 days and irinotecan 125 mg/m2 on days 6, 13, and 20 (Schedule A)
Number of subjects: 32
Study 14758131 — intervention group
Group type: EXPERIMENTAL
Intervention: Temozolomide 200 mg/m2 daily for 5 days and irinotecan 350 mg/m2 on day 6 (Schedule B)
Number of subjects: 32
Study 11474311 — intervention group
Group type: EXPERIMENTAL
Intervention: pantoprazole 20 mg daily
Number of subjects: 396
Study 11474311 — intervention group
Group type: COMPARATOR
Intervention: ranitidine 150 mg daily
Number of subjects: 396
Study 11474311 — intervention group
Group type: EXPERIMENTAL
Intervention: pantoprazole 20 mg daily (H. pylori-positive patients)
Number of subjects: 396
Study 11474311 — intervention group
Group type: EXPERIMENTAL
Intervention: pantoprazole 20 mg daily (H. pylori-negative patients)
Number of subjects: 396
Study 9744238 — intervention group
Group type: EXPERIMENTAL
Intervention: New informative letter
Number of subjects: 185
Study 9744238 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital appointment information
Number of subjects: 185
Study 7920000 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole treatment for 4 to 20 months (mean 10.6 months)
Number of subjects: 15
Study 7920000 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole treatment
Number of subjects: 15
Study 3414572 — intervention group
Group type: EXPERIMENTAL
Intervention: [1‐13C]palmitic acid (9‐13.5 mg/kg body wt)
Number of subjects: 4
Study 3414572 — intervention group
Group type: COMPARATOR
Intervention: [16‐13C]palmitic acid (9‐13.5 mg/kg body wt)
Number of subjects: 4
Study 31269419 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness induction
Number of subjects: 35
Study 31269419 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study 28742643 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hour protocol using sensitive cardiac troponin I (cTnI)
Number of subjects: 64
Study 28742643 — intervention group
Group type: COMPARATOR
Intervention: 4-hour protocol using sensitive cardiac troponin I (cTnI)
Number of subjects: 64
Study 25943999 — intervention group
Group type: EXPERIMENTAL
Intervention: SeniorWISE memory training plus yoga (12 hours total, with a 30-minute yoga component before each session)
Number of subjects: 133
Study 25943999 — intervention group
Group type: EXPERIMENTAL
Intervention: SeniorWISE memory training plus yoga (for those who completed at least 9 hours)
Number of subjects: 133
Study 23561869 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group received soft tissue techniques in the cervical and upper thoracic regions, along with electrotherapy and postural advice.
Number of subjects: 22